Allen Holding Inc.
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 10, 2025), Allen Holding Inc. reported 14 stock positions worth $911.8 million. Its top holding was Coca-Cola (KO) at 41.0% of the portfolio, followed by Berkshire Hathaway Class A (BRK.A, 26.9%) and Palantir Technologies Class A (PLTR, 20.7%). Compared with Q3 2024, it added to 1 and reduced 3. The biggest buy was Pfizer (PFE, shares +2%) and the biggest sale Bank of America (BAC, shares −71%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0000919489
- Portfolio Value
- $911.8M (Q4 2024)
- SEC Filing
- 0001214659-25-002275 ↗ filed Feb 10, 2025
Holdings Value
Holdings 14 stocks · $911.8M
| KO The Coca-Cola Co. | 40.97% | 6,000,000 | $373.6M | No change |
| BRK.A Berkshire Hathaway Inc. Class A | 26.88% | 360 | $245.1M | Reduce -3.5% |
| PLTR Palantir Technologies Inc. Class A | 20.74% | 2,500,000 | $189.1M | Reduce -9.1% |
| PFE Pfizer Inc. | 2.97% | 1,019,800 | $27.1M | Add +2.0% |
| PPLI People Inc. filed as IAC INC | 2.84% | 601,100 | $25.9M | No change |
| AFRM Affirm Holdings Inc. | 1.70% | 255,262 | $15.5M | No change |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 1.45% | 300,000 | $13.2M | Reduce -71.4% |
| JPM JPMorgan Chase & Co. | 0.79% | 30,000 | $7.2M | No change |
| AGX Argan Inc. | 0.36% | 24,000 | $3.3M | No change |
| VMEO Vimeo Inc. | 0.34% | 487,049 | $3.1M | No change |
| ANGI Angi Inc. | 0.31% | 1,700,000 | $2.8M | No change |
| TRIP Tripadvisor Inc. | 0.29% | 181,826 | $2.7M | No change |
| IBRX Immunitybio Inc. | 0.19% | 687,571 | $1.8M | No change |
| MTCH Match Group Inc. | 0.16% | 45,000 | $1.5M | No change |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
| PFE Pfizer Inc. | Add +2.0% | 2.97% | −0.15 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $1.0B | KO, BRK.A, PLTR, PFE, PPLI |
| Q1 2026 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q4 2025 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q3 2025 | 9 | $1.1B | KO, PLTR, BRK.A, PFE, PPLI |
| Q2 2025 | 10 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q1 2025 | 14 | $961.1M | KO, BRK.A, PLTR, PPLI, PFE |
| Q4 2024 | 14 | $911.8M | KO, BRK.A, PLTR, PFE, PPLI |
| Q3 2024 | 14 | $927.1M | KO, BRK.A, PLTR, BAC, PPLI |
| Q2 2024 | 14 | $800.3M | KO, BRK.A, PLTR, BAC, PPLI |
| Q1 2024 | 14 | $794.6M | KO, BRK.A, PLTR, PPLI, BAC |